MA40918A - Nouvelles normalisations et nouveaux dispositifs médicaux pour la préparation de plasma riche en plaquettes (prp) ou de centrifugat de moelle osseuse (bmc) seul ou en association avec de l'acide hyaluronique - Google Patents

Nouvelles normalisations et nouveaux dispositifs médicaux pour la préparation de plasma riche en plaquettes (prp) ou de centrifugat de moelle osseuse (bmc) seul ou en association avec de l'acide hyaluronique

Info

Publication number
MA40918A
MA40918A MA040918A MA40918A MA40918A MA 40918 A MA40918 A MA 40918A MA 040918 A MA040918 A MA 040918A MA 40918 A MA40918 A MA 40918A MA 40918 A MA40918 A MA 40918A
Authority
MA
Morocco
Prior art keywords
prp
bmc
alone
preparation
medical devices
Prior art date
Application number
MA040918A
Other languages
English (en)
Inventor
Antoine Turzi
Original Assignee
Antoine Turzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52292566&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA40918(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Antoine Turzi filed Critical Antoine Turzi
Publication of MA40918A publication Critical patent/MA40918A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/029—Separating blood components present in distinct layers in a container, not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/2013—Piercing means having two piercing ends
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2079—Filtering means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0209—Multiple bag systems for separating or storing blood components
    • A61M1/0218—Multiple bag systems for separating or storing blood components with filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0415—Plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/08—Lipoids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/10—Bone-marrow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Fluid Mechanics (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)

Abstract

La présente invention est relative au domaine de la régénération tissulaire. Il s'agit plus particulièrement de nouvelles standardisations et dispositifs médicaux pour la préparation de a-prp, prp, bmc, tissu adipeux, seuls ou en combinaison avec un biomatériau ou un extrait cellulaire.
MA040918A 2014-11-26 2015-11-26 Nouvelles normalisations et nouveaux dispositifs médicaux pour la préparation de plasma riche en plaquettes (prp) ou de centrifugat de moelle osseuse (bmc) seul ou en association avec de l'acide hyaluronique MA40918A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1421013.2A GB201421013D0 (en) 2014-11-26 2014-11-26 New standardizations & medical devices for the preparation of platelet rich plasma (PRP) or bone marrow centrate (BMC)

Publications (1)

Publication Number Publication Date
MA40918A true MA40918A (fr) 2017-10-04

Family

ID=52292566

Family Applications (2)

Application Number Title Priority Date Filing Date
MA40376A MA40376B1 (fr) 2014-11-26 2015-11-26 Nouvelles normalisations et nouveaux dispositifs medicaux pour la preparation de plasma riche en plaquettes (prp) ou de centrifugat de modele osseuse (bmc) seul ou en association avec de l'acide hyaluronique
MA040918A MA40918A (fr) 2014-11-26 2015-11-26 Nouvelles normalisations et nouveaux dispositifs médicaux pour la préparation de plasma riche en plaquettes (prp) ou de centrifugat de moelle osseuse (bmc) seul ou en association avec de l'acide hyaluronique

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA40376A MA40376B1 (fr) 2014-11-26 2015-11-26 Nouvelles normalisations et nouveaux dispositifs medicaux pour la preparation de plasma riche en plaquettes (prp) ou de centrifugat de modele osseuse (bmc) seul ou en association avec de l'acide hyaluronique

Country Status (25)

Country Link
US (2) US11077241B2 (fr)
EP (2) EP3223875B1 (fr)
JP (2) JP2017536892A (fr)
KR (2) KR102521213B1 (fr)
CN (2) CN107206133A (fr)
AU (2) AU2015352458B2 (fr)
BR (1) BR112017010837B1 (fr)
CA (3) CA2968731C (fr)
CL (1) CL2017001357A1 (fr)
CO (1) CO2017005371A2 (fr)
CR (1) CR20170288A (fr)
DO (1) DOP2017000128A (fr)
EA (1) EA035982B1 (fr)
EC (1) ECSP17039547A (fr)
GB (1) GB201421013D0 (fr)
IL (2) IL284309B (fr)
MA (2) MA40376B1 (fr)
MX (1) MX2017006974A (fr)
NI (1) NI201700064A (fr)
PE (1) PE20170931A1 (fr)
PH (1) PH12017500946A1 (fr)
SG (1) SG11201704218PA (fr)
TN (1) TN2017000220A1 (fr)
UA (1) UA123822C2 (fr)
WO (1) WO2016083549A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3413958A4 (fr) * 2016-02-09 2019-11-06 Marc Waisman Pinces-aiguilles à os et pointes d'aiguilles canulées destinées à être utilisées en tant qu'aiguilles de perfusion squelettique et procédés associés
AU2017230806B2 (en) 2016-03-10 2021-06-24 Arthrex, Inc. Systems and methods for preparing a thrombin serum
EP3426400B1 (fr) 2016-03-10 2020-09-02 Arthrex Inc Système de préparation de sérums enrichis en protéines
EP3436054B2 (fr) 2016-09-13 2022-07-27 Allergan, Inc. Compositions de toxines clostridiales non protéiques
CN106701674A (zh) * 2016-12-29 2017-05-24 上海新肌生物科技有限公司 一种提高移植性脂肪细胞或者填充式脂肪细胞成活率的复活因子的提纯和萃取工艺
IT201700003805A1 (it) * 2017-01-16 2018-07-16 Univ Campus Bio Medico Di Roma Tecnica di purificazione del tessuto adiposo per ottenere alta concentrazione di cellule staminali adipose
KR102199048B1 (ko) * 2017-11-29 2021-01-06 사회복지법인 삼성생명공익재단 골수 흡인 농축물-혈소판 농축혈장 복합체로 구성된 건병증 예방 또는 치료용 약학적 조성물
CN108451627B (zh) * 2018-04-04 2023-11-17 中国人民解放军总医院 一种骨修复材料共混装置
TR201815514A2 (tr) * 2018-10-18 2018-11-21 T Biyoteknoloji Laboratuvar Estetik Medikal Kozmetik San Tic Ltd Sti Trombosi̇t zengi̇n plazma elde etmek üzere bi̇r yöntem
CN109513037B (zh) * 2018-11-14 2021-09-17 华中科技大学同济医学院附属协和医院 一种负载介孔生物玻璃的小肠粘膜下层创面敷料
CA3127191A1 (fr) 2019-01-21 2020-07-30 Eclipse Medcorp, Llc Procede, systeme et appareil pour separer des composants d'un echantillon biologique
GB201901671D0 (en) * 2019-02-06 2019-03-27 Regen Lab Sa Cross-linked hya;uronic acids and combinations with PRP/BMC
CA3159372A1 (fr) 2019-10-31 2021-05-06 Eclipse Medcorp, Llc Systemes, procedes et appareil de separation de constituants d'un echantillon
EP3875074A1 (fr) * 2020-03-05 2021-09-08 Novystem S.p.A. Préparation de sang utile pour la cicatrisation des plaies et la régénération des tissus
CN111334468B (zh) * 2020-03-12 2024-08-06 青岛农业大学 一种低分子量透明质酸片段诱发血红细胞钱串状聚集的应用
CN111468204A (zh) * 2020-06-08 2020-07-31 珠海朗泰生物科技有限公司 一种可控组分的富血小板血浆制备管及其制备方法
AU2022283171A1 (en) * 2021-05-27 2024-01-04 Prp Concepts, Inc. Methods and systems for preparation of mononuclear-platelet rich fibrin matrix, and compounds thereof
CA3223320A1 (fr) * 2021-06-25 2022-12-29 Antoine Turzi Procede de preparation et recipient pour un gel topique de cicatrisation de plaie
WO2023004101A1 (fr) * 2021-07-23 2023-01-26 Nivagen Pharmaceuticals, Inc. Formulation de gluconate de calcium sans saccharate de calcium
IL289281B2 (en) * 2021-12-22 2023-06-01 Reddress Ltd Method and kit for the treatment of damaged connective tissues
CN115960826B (zh) * 2022-12-07 2023-10-17 上海医涯医疗科技有限公司 一种细胞水平离心分离方法
GB202219505D0 (en) 2022-12-22 2023-02-08 Turzi Antoine Medical composition

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852194A (en) 1972-12-11 1974-12-03 Corning Glass Works Apparatus and method for fluid collection and partitioning
US4101422A (en) 1977-05-11 1978-07-18 Emery Industries, Inc. Copolyesters useful in blood separation assemblies
US4350593A (en) 1977-12-19 1982-09-21 Becton, Dickinson And Company Assembly, compositions and method for separating blood
US4190535A (en) 1978-02-27 1980-02-26 Corning Glass Works Means for separating lymphocytes and monocytes from anticoagulated blood
JPS6090039A (ja) * 1983-10-21 1985-05-21 Asahi Chem Ind Co Ltd 血液浄化吸着体
US5236604A (en) 1991-05-29 1993-08-17 Sherwood Medical Company Serum separation blood collection tube and the method of using thereof
US5459030A (en) * 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
BE1006620A5 (fr) * 1992-07-13 1994-11-03 Pall Corp Systeme automatise et methode de traitement de fluides biologiques.
US5560830A (en) 1994-12-13 1996-10-01 Coleman; Charles M. Separator float and tubular body for blood collection and separation and method of use thereof
US5510102A (en) * 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
US6020196A (en) * 1996-05-09 2000-02-01 Baxter International Inc. Devices for harvesting and homogenizing adipose tissue containing autologous endothelial cells
US5906744A (en) 1997-04-30 1999-05-25 Becton Dickinson And Company Tube for preparing a plasma specimen for diagnostic assays and method of making thereof
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
JP4493857B2 (ja) * 1998-04-20 2010-06-30 メドトロニック，インコーポレイテッド 自家移植フィブリンシーラント及び同種を作成する方法
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
US20020187130A1 (en) 2001-01-23 2002-12-12 George Kindness Adjuvant immune therapy in the treatment of solid tumors through modulation of signaling pathways following engagement of humoral and cell mediated responses
US7264608B2 (en) * 2001-12-05 2007-09-04 Fenwal, Inc. Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
JP2006500317A (ja) * 2002-02-28 2006-01-05 バイオピュア コーポレーション 分離およびダイアフィルトレーションによる赤血球の精製
US7553413B2 (en) * 2005-02-07 2009-06-30 Hanuman Llc Plasma concentrator device
AU2003230270A1 (en) * 2002-05-07 2003-11-11 Becton, Dickinson And Company Collection assembly
JPWO2004012750A1 (ja) 2002-08-02 2006-11-30 東レ株式会社 血小板多血漿の調製方法
US7291450B2 (en) * 2003-03-28 2007-11-06 Smith & Nephew, Inc. Preparation of a cell concentrate from a physiological solution
JP4558401B2 (ja) * 2004-07-26 2010-10-06 テルモ株式会社 血液成分採取装置
JP2006232834A (ja) * 2005-02-23 2006-09-07 Allan Mishra 組織損傷の治療のための方法及びキット
WO2006123579A1 (fr) * 2005-05-17 2006-11-23 National University Corporation Nagoya University Procede de preparation cellulaire pour la formation de tissu osseux et application de cellule pour la formation de tissu osseux
WO2008022651A1 (fr) * 2006-08-21 2008-02-28 Antoine Turzi Procédé et dispositif de préparation de plasma riche en plaquettes pour utilisation impromptue et sa combinaison avec des cellules cutanées et osseuses
CN102223907B (zh) * 2008-11-25 2014-07-02 旭化成医疗株式会社 Hla-dr阳性单核细胞选择去除器及抗氧化剂用于制造该选择去除器的用途
KR20100116106A (ko) 2009-04-21 2010-10-29 에스타 테크날러지스 리미티드 혈소판 농축 혈장 조성용 조립체, 키트, 및 그 방법
US9090752B2 (en) 2009-07-21 2015-07-28 Andrey Ponomarev Multi-layered carbon nanoparticles of the fulleroid type
US7927563B1 (en) * 2009-10-13 2011-04-19 Cytomedix, Inc. Kit for separation of biological fluids
KR101069877B1 (ko) * 2009-10-28 2011-10-05 임기표 원심분리 키트 및 이를 이용한 원심분리 방법
ES2897598T3 (es) * 2009-11-27 2022-03-01 Stempeutics Res Pvt Ltd Métodos de preparación de células madre mesenquimales, composiciones y kit de las mismas
GB201004072D0 (en) * 2010-03-11 2010-04-28 Turzi Antoine Process, tube and device for the preparation of wound healant composition
JP2012105721A (ja) * 2010-11-15 2012-06-07 National Cerebral & Cardiovascular Center カフ部材及びその製造方法
JP5738582B2 (ja) * 2010-12-06 2015-06-24 株式会社カネカ プライミング時の気泡の除去を簡便にする部材を備えた細胞溶液処理器具およびその使用方法
US9164079B2 (en) * 2011-03-17 2015-10-20 Greyledge Technologies Llc Systems for autologous biological therapeutics
KR20120136730A (ko) * 2011-06-10 2012-12-20 코오롱생명과학 주식회사 생체 적합성이 우수한 변성 히알루론산의 제조방법
EP2590178A1 (fr) * 2011-07-21 2013-05-08 Services Pétroliers Schlumberger Équipement et procédés pour déployer une ligne dans un puits
GB201118586D0 (en) * 2011-10-27 2011-12-07 Turzi Antoine New A-PRP medical device, manufacturing machine and process
EP2806914B1 (fr) * 2012-01-23 2021-09-22 Estar Technologies Ltd Système et procédé pour l'obtention d'un échantillon cellulaire enrichi en cellules précises tel que le plasma riche en plaquettes (prp)
ITGE20120034A1 (it) * 2012-03-28 2013-09-29 Carlo Tremolada Preparato e metodo per la produzione di un preparato comprendente cellule staminali mesenchimali
JP5592450B2 (ja) * 2012-09-18 2014-09-17 大日精化工業株式会社 自走細胞捕捉具
FR2996413B1 (fr) * 2012-10-10 2014-12-05 Maco Pharma Sa Procede pour conserver le sang placentaire
EP3027235A1 (fr) * 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Matrices dérivées de tissu mou acellulaire et leurs procédés de préparation
WO2015048344A2 (fr) * 2013-09-27 2015-04-02 Tufts University Composition de plaquette/soie et utilisation de celle-ci
TWM475927U (en) * 2013-12-17 2014-04-11 Maria Von Med-Biotechnology Co Ltd Device for isolating plasma from whole blood samples
EP3104708A4 (fr) * 2014-02-10 2017-08-09 Cytori Therapeutics, Inc. Thérapie cellulaire régénérative pour troubles du système nerveux central (snc) et espt
ES2838600T3 (es) * 2014-04-17 2021-07-02 Healeon Medical Ltd Aparato para la preparación y administración de componentes sanguíneos

Also Published As

Publication number Publication date
EP3903844A1 (fr) 2021-11-03
SG11201704218PA (en) 2017-06-29
CA3199712A1 (fr) 2016-06-02
CR20170288A (es) 2017-08-10
CO2017005371A2 (es) 2017-10-31
GB201421013D0 (en) 2015-01-07
DOP2017000128A (es) 2017-08-15
MA40376B1 (fr) 2019-11-29
IL252536B (en) 2021-07-29
BR112017010837A2 (pt) 2017-12-26
JP2018164757A (ja) 2018-10-25
PE20170931A1 (es) 2017-07-13
KR20220025185A (ko) 2022-03-03
ECSP17039547A (es) 2017-12-01
WO2016083549A3 (fr) 2016-07-28
JP2017536892A (ja) 2017-12-14
EP3223875A2 (fr) 2017-10-04
KR102362722B1 (ko) 2022-02-14
CA2968731C (fr) 2023-11-21
EA035982B1 (ru) 2020-09-09
KR20170088366A (ko) 2017-08-01
MA40376A1 (fr) 2019-03-29
EP3223875B1 (fr) 2022-01-05
WO2016083549A2 (fr) 2016-06-02
EA201791084A1 (ru) 2017-09-29
AU2015352458A1 (en) 2017-06-15
US20210346587A1 (en) 2021-11-11
US11077241B2 (en) 2021-08-03
CN107206133A (zh) 2017-09-26
CN118121632A (zh) 2024-06-04
PH12017500946A1 (en) 2017-11-27
US20180110917A1 (en) 2018-04-26
CA3199798A1 (fr) 2016-06-02
TN2017000220A1 (en) 2018-10-19
IL252536A0 (en) 2017-07-31
IL284309A (en) 2021-07-29
BR112017010837B1 (pt) 2022-09-27
UA123822C2 (uk) 2021-06-09
NI201700064A (es) 2017-09-22
CL2017001357A1 (es) 2018-03-02
IL284309B (en) 2022-07-01
AU2015352458B2 (en) 2020-11-19
MX2017006974A (es) 2018-02-09
NZ732158A (en) 2023-12-22
KR102521213B1 (ko) 2023-04-14
AU2021201102B2 (en) 2022-09-29
AU2021201102A1 (en) 2021-03-11
CA2968731A1 (fr) 2016-06-02

Similar Documents

Publication Publication Date Title
MA40918A (fr) Nouvelles normalisations et nouveaux dispositifs médicaux pour la préparation de plasma riche en plaquettes (prp) ou de centrifugat de moelle osseuse (bmc) seul ou en association avec de l'acide hyaluronique
PH12019502003A1 (en) Cyclic sulfamide compounds and methods of using same
DOP2017000186A (es) Agentes inductores de apoptosis para el tratamiento del cáncer y de enfermedades inmunes y autoinmunes
DOP2012000297A (es) Agentes inductores de apoptosis para el tratamiento del cancer y de enfermedades inmunes y autoinmunes
EA202092627A1 (ru) Соединения и их применения для модуляции гемоглобина
EA202191513A1 (ru) Снижение вязкости фармацевтических составов
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
WO2018088875A3 (fr) Cellule tueuse naturelle contenant une mitochondrie exogène et composition pharmaceutique la comprenant
EA201991951A1 (ru) Низковязкие высококонцентрированные составы на основе эволокумаба и способы их получения
WO2015123493A3 (fr) Compositions et méthodes de modulation de réponse immunitaire
MX362471B (es) Composiciones para el cuidado bucal que tienen estabilidad mejorada.
CO2020016105A2 (es) Proteínas inmunodominantes y fragmentos en esclerosis múltiple
EA201891610A1 (ru) Производные 3-(карбоксиэтил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана
WO2015159308A3 (fr) Formulation ostéo-inductrice et préparation associée
BR112021022293A2 (pt) Composições de oligossacarídeos e métodos de uso das mesmas
EA201692051A1 (ru) Арилзамещенные гетероциклилсульфоны
WO2016083767A3 (fr) Traitement épithélial
EA201792130A1 (ru) Композиции, содержащие adamts13, для применения в способах реканализации окклюзированных кровеносных сосудов при инфаркте
GR1008769B (el) Οξινο διαλυμα αιμοκαθαρσης με l-ασκορβικο οξυ (βιταμινη c)
MY170270A (en) Method to extract leech hirudin
EA201990074A1 (ru) Гетероциклические соединения как иммуномодуляторы
EA201892095A1 (ru) Циклические динуклеотидные соединения и способы их применения
Sadikova et al. INFLUENCE OF GLUFIMET, A NEW DERIVATIVE OF GLUTAMIC ACID, ON THE HEMOSTATIC SYSTEM OF STRESSED ANIMALS
RU2014146334A (ru) Способ получения стандартизованной концентрации ядросодержащих клеток из пуповинной крови
MY175380A (en) Apheresis bowl with improved vibration characteristics